About Abcam Plc (LON:ABC)
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company's purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways. The Company is engaged in data sharing and ecommerce in the life sciences. The Company focuses on helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use its affinity binders, reagents, biomarkers and assays and the Company's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences. It has approximately 10 locations located in the world, through life science research hubs, enabling local services and multi-language support.
Industry, Sector and Symbol:
- Industry: Biopharmaceuticals
- Sub-Industry: N/A
- Sector: N/A
- Symbol: LON:ABC
- CUSIP: N/A
- Web: www.abcam.com
- Trailing EPS: GBX 0.21
- Net Margins: 19.67%
- Return on Equity: 15.03%
- Return on Assets: 12.58%
- Outstanding Shares: 204,640,000
Frequently Asked Questions for Abcam Plc (LON:ABC)
What is Abcam Plc's stock symbol?
Abcam Plc trades on the London Stock Exchange (LON) under the ticker symbol "ABC."
How often does Abcam Plc pay dividends? What is the dividend yield for Abcam Plc?
Abcam Plc declared a dividend on Monday, September 11th. Investors of record on Thursday, November 16th will be paid a dividend of GBX 7.36 per share on Friday, December 8th. This represents a yield of 0.71%. The ex-dividend date is Thursday, November 16th. This is a boost from Abcam Plc's previous dividend of $2.83. The official announcement can be seen at this link. View Abcam Plc's Dividend History.
Where is Abcam Plc's stock going? Where will Abcam Plc's stock price be in 2017?
6 equities research analysts have issued 1-year price targets for Abcam Plc's stock. Their forecasts range from GBX 680 to GBX 1,200. On average, they anticipate Abcam Plc's stock price to reach GBX 972.67 in the next year. View Analyst Ratings for Abcam Plc.
Who are some of Abcam Plc's key competitors?
Some companies that are related to Abcam Plc include Auxilium Pharmaceuticals (AUXL), Horizon Therapeutics (HPTX), Myovant Sciences (MYOV), Anika Therapeutics (ANIK), Vitae Pharmaceuticals (VTAE), Sinovac Biotech (SVA), 3SBio (SSRX), ChemoCentryx (CCXI), Syros Pharmaceuticals (SYRS), Kadmon Holdings (KDMN), Mereo BioPharma Group plc (MPH), Strongbridge Biopharma PLC (SBBP), Syndax Pharmaceuticals (SNDX), Peregrine Pharmaceuticals (PPHM), Fortress Biotech (FBIO), Kamada (KMDA), Mirna Therapeutics (SYBX) and Vericel Corporation (VCEL).
Who are Abcam Plc's key executives?
Abcam Plc's management team includes the folowing people:
- Alan Thomas Hirzel, Chief Executive Officer, Executive Director
- Gavin Hilary James Wood, Chief Financial Officer, Executive Director (Age 46)
- Suzanne Elaine Smith, Chief Legal Officer, Company Secretary
- Jonathan Simon Milner Ph.D., Deputy Chairman of the Board
- Murray Edwin Hennessy, Chief Executive Officer (Age 51)
- Mara Glickman Aspinall, Interim Senior Independent Non-Executive Director (Age 54)
- Susan Elizabeth Harris, Non-Executive Director (Age 54)
- Louise A. V. C. Patten, Interim Non-Executive Chairman of the Board (Age 63)
How do I buy Abcam Plc stock?
Shares of Abcam Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Abcam Plc's stock price today?
One share of Abcam Plc stock can currently be purchased for approximately GBX 971.50.
How big of a company is Abcam Plc?
Abcam Plc has a market capitalization of £1.97 billion.
How can I contact Abcam Plc?
Abcam Plc's mailing address is 330 Cambridge Science Park, CAMBRIDGE, CB4 0FL, United Kingdom. The company can be reached via phone at +44-1223-696000.
MarketBeat Community Rating for Abcam Plc (LON ABC)MarketBeat's community ratings are surveys of what our community members think about Abcam Plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Abcam Plc (LON:ABC) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 4 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings|
|Consensus Rating:||Hold (Score: 2.00)|
|Consensus Price Target: ||GBX 972.67|
Consensus Price Target History for Abcam Plc (LON:ABC)
Analysts' Ratings History for Abcam Plc (LON:ABC)
(Data available from 11/20/2015 forward)
|10/31/2017||Peel Hunt||Reiterated Rating||Hold||GBX 1,020|
|9/18/2017||J P Morgan Chase & Co||Boost Price Target||Neutral||GBX 864 -> GBX 946|
|9/12/2017||Numis Securities Ltd||Boost Price Target||Add||GBX 1,116 -> GBX 1,200|
|9/11/2017||Berenberg Bank||Reiterated Rating||Buy||GBX 1,100|
|9/11/2017||Panmure Gordon||Reiterated Rating||Sell|
|5/2/2017||Stifel Nicolaus||Reiterated Rating||Hold||GBX 890|
|4/4/2016||Royal Bank Of Canada||Initiated Coverage||Sector Performer||GBX 610|
Earnings History for Abcam Plc (LON:ABC)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Abcam Plc (LON:ABC)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History by Quarter for Abcam Plc (LON ABC)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Abcam Plc (LON ABC)
Insider Trades by Quarter for Abcam Plc (LON ABC)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/21/2017||Jonathan Simon Milner||Insider||Sell||567,033||GBX 1,017||£5,766,725.61|
|9/14/2017||Louise Patten||Insider||Buy||1,636||GBX 1,079||£17,652.44|
|6/5/2017||Mara G Aspinall||Insider||Buy||2,700||GBX 979||£26,433|
|3/22/2017||Alan Thomas Hirzel||Insider||Buy||6,000||GBX 809||£48,540|
|3/20/2017||Alan Thomas Hirzel||Insider||Buy||6,000||GBX 839||£50,340|
|12/8/2016||Mara G Aspinall||Insider||Buy||298||GBX 786||£2,342.28|
|12/7/2016||Alan Thomas Hirzel||Insider||Buy||227||GBX 792||£1,797.84|
|12/2/2016||P. Warwick||Insider||Sell||30,000||GBX 808||£242,400|
|9/30/2016||Louise Patten||Insider||Buy||12,378||GBX 836||£103,480.08|
|9/19/2016||Milner,Jonathan Simon||Insider||Sell||20,361||GBX 820||£166,960.20|
|11/11/2015||Hirzel,Alan Thomas||Insider||Buy||3,335||GBX 580||£19,343|
|9/18/2015||Hirzel,Alan Thomas||Insider||Buy||4,000||GBX 615||£24,600|
|3/26/2015||Jonathan Simon Milner||Insider||Sell||2,480,000||GBX 465||£11,532,000|
Latest Headlines for Abcam Plc (LON ABC)
|Global Immunochemicals Industry|
www.bizjournals.com - November 17 at 3:15 PM
|ETFs with exposure to Abcam Plc : November 16, 2017|
finance.yahoo.com - November 16 at 3:33 PM
|Abcam Plc (ABC) Plans Dividend of GBX 7.36|
www.americanbankingnews.com - November 11 at 9:54 AM
|Abcam Plc breached its 50 day moving average in a Bullish Manner : ABC-GB : November 6, 2017|
finance.yahoo.com - November 6 at 4:03 PM
|ETFs with exposure to Abcam Plc : November 6, 2017|
finance.yahoo.com - November 6 at 4:02 PM
|Abcam Plc :ABC-GB: Earnings Analysis: For the six months ended June 30, 2017 : November 2, 2017|
finance.yahoo.com - November 2 at 8:22 PM
|Top 4 Inexpensive Mutual Funds for Global Growth in 2018 - Nasdaq|
www.nasdaq.com - November 1 at 3:11 PM
|Abcam Plc (ABC) Given Average Rating of "Hold" by Brokerages|
www.americanbankingnews.com - November 1 at 1:52 AM
|ETFs with exposure to Abcam Plc : October 27, 2017|
finance.yahoo.com - October 27 at 5:26 PM
|Wasatch Sells More Than 1% Stake In ABCAM For About GBP23 Million (ALLISS)|
www.morningstar.co.uk - October 17 at 3:17 PM
|ETFs with exposure to Abcam Plc : October 17, 2017|
finance.yahoo.com - October 17 at 3:17 PM
|Abcam Chairman Leaves Role For Chief Executive Position In US|
www.morningstar.co.uk - October 11 at 8:29 PM
|Abcam Plc (ABC) Receives Consensus Rating of "Hold" from Analysts|
www.americanbankingnews.com - October 7 at 2:52 AM
|Global Multiplex Biomarker Imaging Market to Touch US$ 843 Mn by 2027 - Future Market Insights|
www.marketwatch.com - October 4 at 8:08 AM
|ETFs with exposure to Abcam Plc : October 3, 2017|
finance.yahoo.com - October 3 at 3:08 PM
|Abcam Plc :ABC-GB: Earnings Analysis: 2017 By the Numbers : September 29, 2017|
finance.yahoo.com - October 2 at 3:06 PM
|Abcam Plc (ABC) Price Target Increased to GBX 1,020 by Analysts at Peel Hunt|
www.americanbankingnews.com - September 24 at 9:14 AM
|DIRECTOR DEALINGS: ABCAM Deputy Chair Lowers Stake By Million Shares|
www.morningstar.co.uk - September 23 at 9:37 AM
|Abcam Plc (ABC) Insider Sells £5,766,725.61 in Stock|
www.americanbankingnews.com - September 22 at 7:20 AM
|Abcam Plc – Value Analysis (LONDON:ABC) : September 19, 2017|
finance.yahoo.com - September 19 at 8:20 PM
|Is It Time To Buy Abcam Plc (AIM:ABC)?|
finance.yahoo.com - September 19 at 3:19 PM
|Abcam Plc breached its 50 day moving average in a Bearish Manner : ABC-GB : September 18, 2017|
finance.yahoo.com - September 18 at 3:24 PM
|Louise Patten Buys 1,636 Shares of Abcam Plc (ABC) Stock|
www.americanbankingnews.com - September 18 at 1:16 PM
|Numis Securities Ltd Boosts Abcam Plc (ABC) Price Target to GBX 1,200|
www.americanbankingnews.com - September 12 at 7:02 AM
|Why I’d avoid this double-bagger and buy Premier Oil plc|
www.fool.co.uk - September 12 at 1:49 AM
|Abcam Lifts Dividend 14% As Annual Revenue And Profit Both Rise|
www.morningstar.co.uk - September 12 at 1:49 AM
|Abcam Lifts Dividend 14% As Annual Revenue And Profit Both Rise - London South East (registration) (blog)|
www.lse.co.uk - September 11 at 3:44 PM
|Berenberg Bank Reaffirms "Buy" Rating for Abcam Plc (ABC)|
www.americanbankingnews.com - September 11 at 10:10 AM
|Abcam Plc (ABC) Given Sell Rating at Panmure Gordon|
www.americanbankingnews.com - September 11 at 9:04 AM
|Abcam Plc (ABC) Scheduled to Post Earnings on Monday|
www.americanbankingnews.com - September 4 at 1:52 AM
|CEA (Carcinoembryonic Antigen) Market Expected to Grow at More Than 6.6% CAGR From 2012 to 2022: Million Insights|
www.bizjournals.com - August 28 at 3:29 PM
|Abcam Plc (ABC) Earns "Hold" Rating from Peel Hunt|
www.americanbankingnews.com - August 20 at 12:50 AM
|Panmure Gordon Reaffirms Sell Rating for Abcam Plc (ABC)|
www.americanbankingnews.com - July 27 at 11:21 AM
|Abcam Plc (ABC) Given "Add" Rating at Numis Securities Ltd|
www.americanbankingnews.com - July 27 at 10:53 AM
|Abcam Plc (LON:ABC) Receives Consensus Rating of "Hold" from Analysts|
www.americanbankingnews.com - July 24 at 10:56 AM
|OraSure Technologies (OSUR) Names Mara Aspinall to Board|
www.streetinsider.com - June 22 at 6:32 PM
|Protein Assays Market expected to reach USD 2.41 billion in 2022|
www.prnewswire.com - June 6 at 3:19 PM
|Allscripts Healthcare Solutions (MDRX) Appoints Mara Aspinall to Director|
www.streetinsider.com - May 26 at 1:37 AM
|DIRECTOR DEALINGS: Abcam Finance Boss Gavin Wood Ups Interest|
www.morningstar.co.uk - May 3 at 3:17 PM
|Global Multiplex Assays Market Expected to Reach $5,720 Million by 2022 - Allied Market Research|
www.bizjournals.com - April 20 at 3:15 PM
|This biotech stock is already worth £1.7bn — is it still a buy?|
uk.finance.yahoo.com - March 17 at 3:18 PM
|BRIEF-Abcam H1 pretax profit rises|
www.businessinsider.com - March 7 at 3:16 PM
|UPDATE 2-UK Stocks-Factors to watch on March 6 - Reuters|
www.reuters.com - March 6 at 10:09 AM
|Can these £1.7bn AIM growth stocks double again?|
uk.finance.yahoo.com - March 6 at 10:09 AM
Financials are not available for this stock.
Abcam Plc (LON ABC) Chart for Monday, November, 20, 2017